$1550.00 - $4652.00
H-Val-Ala-Gly-Gly-Phe-Gly-PAB is a peptide-PAB linker intermediate built around the Val-Ala-Gly-Gly-Phe-Gly motif and a para-aminobenzyl (PAB) spacer. It is intended for research on cleavable linker architecture, linker assembly and bioconjugation chemistry rather than as a free bioactive peptide.
The product is best understood as a modular synthetic intermediate: the peptide sequence provides an enzyme-responsive segment in relevant linker designs, while the PAB unit is commonly used as a self-immolative spacer in drug-linker chemistry. Lot-specific identity and purity should be confirmed before incorporation into a conjugation workflow.
Product Information
| Product Name | H-Val-Ala-Gly-Gly-Phe-Gly-PAB |
| Catalog No. | AS4086 |
| Molecular Formula | C30H41N7O7 |
| Molecular Weight | 611.70 g/mol |
| Sequence / Identity | Val-Ala-Gly-Gly-Phe-Gly-PAB |
| Synonym | Val-Ala-Gly-Gly-Phe-Gly-PAB |
| Primary Research Use | peptide-PAB linker research |
Role in Cleavable Linker Research
The Val-Ala-Gly-Gly-Phe-Gly-PAB architecture is relevant to peptide-cleavable linker development. In established ADC designs, GGFG-containing sequences can be combined with PAB-type self-immolative spacers so that enzymatic cleavage and spacer fragmentation are separated functions. For AS4086, the extended Val-Ala-GGFG sequence should be treated as a research linker precursor unless cleavage behavior is validated in the intended system.
Distinguishing the PAB Precursor from Activated Linkers
This material is not the same as MC-GGFG-PAB-PNP, PAB-PNP, or a payload-conjugated linker. Those products contain additional reactive or activated groups. Match the exact structure to the planned linker-assembly step before ordering.
Procurement and QC Considerations
Confirm the exact peptide sequence, PAB termination, molecular mass and HPLC/MS identity. PAB-containing linker intermediates can be confused with activated PNP carbonates or maleimide-containing derivatives, which are different products and should not share a CAS or specification.
Related materials can be reviewed under impurity and research standards.
For broader sequence or project work, see peptide linker synthesis.
Linker Identity and Reactive-State Control
Peptide-PAB intermediates should be ordered against the exact sequence and terminal chemical state. PAB-OH, activated PAB derivatives and payload-bearing linkers are different materials and can show similar naming across supplier catalogs.
For linker assembly, lot-specific HPLC and mass data are useful for confirming the intended intermediate before conjugation. If a prepared solution will be stored or reused, solution stability should be established under the selected solvent and concentration conditions.
Product Documents
MSDS - H-Val-Ala-Gly-Gly-Phe-Gly-PAB (AS4086)
The Safety Data Sheet provides product identification, laboratory handling guidance, exposure controls, transport information and safety information for research use.
Certificates of Analysis (COAs) are batch-specific. Please contact us to request the COA for your product, and we will provide it by email.
Frequently Asked Questions
What is H-Val-Ala-Gly-Gly-Phe-Gly-PAB?
It is Val-Ala-Gly-Gly-Phe-Gly-PAB, a defined research compound with sequence or structural identity Val-Ala-Gly-Gly-Phe-Gly-PAB.
Is this a complete antibody-drug conjugate linker?
No. It is a peptide-PAB linker intermediate and does not by itself include every conjugation handle, activation group or payload component used in a complete ADC linker.
Why is the exact PAB termination important?
PAB-OH, PAB-PNP and other activated PAB derivatives are chemically different intermediates with different downstream reactivity.